000952.SZ
广济药业
SZSE · Healthcare · C 制造业 · CN
CNY 6.32
−0.94%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−9.1x
Market Cap
CNY 2.17B
MomentumView details →
1D Return
−0.94%
YTD Return
−8.53%
RSI (14)
54.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−9.1x
Market Cap
CNY 2.17B
RSI (14)
54.8
MomentumView details →
1D Return
−0.94%
YTD Return
−8.53%
Similar companies
Latest newsMore news →
Guangji Pharmaceutical announced its first-half 2026 results, reporting a net loss attributable to shareholders of 57.9451 million yuan, compared with a loss of 75.5151 million yuan in the same period of 2025.8d agoGuangji Pharmaceutical announced that its application for a 2026 private placement of shares was accepted by the Shenzhen Stock Exchange on August 26, 2026.9d ago